Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR-66.1%
5Y CAGR-63.3%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-66.1%/yr
vs +36.5%/yr prior
5Y CAGR
-63.3%/yr
Consistent
Acceleration
-102.7pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 1.84% |
| 2024 | -39.31% |
| 2023 | 11.10% |
| 2022 | 47.29% |
| 2021 | 137.52% |
| 2020 | 277.47% |
| 2019 | 100.01% |
| 2018 | 13.61% |
| 2017 | 25.72% |
| 2016 | 878.85% |